首页 | 本学科首页   官方微博 | 高级检索  
   检索      

慢性乙型肝炎抗病毒治疗研究进展
引用本文:田群,左维泽,曹玉文.慢性乙型肝炎抗病毒治疗研究进展[J].生物磁学,2011(21):4187-4190.
作者姓名:田群  左维泽  曹玉文
作者单位:[1]石河子大学医学院第一附属医院感染科,新疆石河子832008 [2]石河子大学医学院,新疆石河子832008
摘    要:乙肝病毒的慢性感染是肝纤维化、肝细胞癌的重要病因,积极有效地抗病毒治疗,可显著改善HBV感染者的生活质量。干扰素、核苷(酸)类药物的抗乙肝病毒疗效已得到全球公认,本文就上述两类药物的研究进展进行综述。

关 键 词:慢性乙型肝炎  抗病毒治疗  干扰素  核苷类药物

Update on the Anti-Viral Treatment of Chronic Hepatitis B
TIAN Qun,ZUO Wei-ze,CAO Yu-wen.Update on the Anti-Viral Treatment of Chronic Hepatitis B[J].Biomagnetism,2011(21):4187-4190.
Authors:TIAN Qun  ZUO Wei-ze  CAO Yu-wen
Institution:1 Department of infectious disease, the First Affiliated Hospital of the Medical College, Shihezi University,832008; 2 Shihezi University School of Medicine, Shihezi 832008, China)
Abstract:The chronic HBV infection is the main factor of the complications of cirrhosis and hepatocellular carcinoma. All patients who are positive for hepatitis B virus (HBV) DNA should be considered for antiviral treatment. It will improve their life. Interfron-α and nucleoside and nucleotide analogues constitute the most potent of the antiviral therapy. The article reviewed the latest advancement of Hepatitis B antiviral therapy.
Keywords:Chronic hepatitis B  Antiviral therapy  Interferon-α  Nucleoside and nucleotide analogues
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号